Firing up innate immunity to stop asthma attacks

submitted by: mdanderson
The National Institutes of Health will provide $2.4 million to an MD Anderson researcher to advance a completely new approach to stifling asthma attacks. Scott Evans, M.D., of MD Anderson's Department of Pulmonary Medicine, was named an NIH New Innovator for his proposal to jump-start a rapid immune response to stymie viral infections before they can provoke asthma attacks. "Asthma affects 8 percent of Americans -- 26 million adults and children -- and its incidence continues to grow for...

Use it or lose it: Eating and swallowing exercises show benefit in throat cancer patients

submitted by: mdanderson

Kate Hutcheson, Ph.D., assistant professor in the Department of Head and Neck Surgery, discusses a new study examining the benefits of swallowing and eating exercises for patients undergoing radiation and chemotherapy for head and neck cancers.

Why are HPV-related oral cancers on the rise?

submitted by: mdanderson

The number of oral cancer cases is increasing significantly due largely to the human papillomavirus (HPV), a sexually transmitted disease that's most commonly spread through oral sex.

By 2020, HPV may cause more cases of throat cancer than cervical cancer.

Watch Erich Sturgis, M.D., professor of Head and Neck Surgery at MD Anderson, talk about why HPV-related oral cancers, including throat cancer, are becoming more common.

Diffuse large b-cell lymphoma

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/diffuse-large-b-cell-lymphoma/id431... Diffuse large b-cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL). DLBCL is fast growing and can develop in lymph nodes, gastrointestinal tract, testicles, thyroid, skin, brain, bone or breast. Jason Westin, M.D., assistant professor in Lymphoma/Myeloma at MD Anderson Cancer Center, discusses symptoms, diagnosis and treatment of diffuse large b-cell lymphoma.

Ovarian cancer screening with simple blood test

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/ovarian-cancer-screening-simple/id4... A simple blood test currently approved to detect ovarian cancer disease recurrence is full of new possibility. It may, one day, detect invasive, high-grade disease at its earliest, most curable stage. Listen to Karen Lu, M.D., professor and chair of Gynecologic Oncology and Reproductive Medicine, as she details the findings, and what they could, one day, mean for women.

Penile cancer basics

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/penile-cancer-basics/id431848216?i=... . Penile cancer is rare with less than 2,000 men being diagnosed in the US each year and around 26,000 worldwide. If caught early, penile cancer is curable but men tend to ignore symptoms until the disease has advanced. Lance Pagliaro, M.D., professor in Genitourinary Medical Oncology at MD Anderson Cancer Center, discusses the basics, symptoms, diagnosis and treatment of penile cancer.